Clinical Trials Logo
  1. Home
  2. Stimulant Use
  3. NCT05787847

Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program

Stimulant Use Clinical Trial

Official title:
Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program

Clinical Trial Summary

The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.

Clinical Trial Description

The investigators are proposing a two condition, parallel groups, randomized control pilot study to evaluate the efficacy of a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The study design will include recruiting service recipients who already participate in programs offered by a syringe exchange program.The experimental group will have the opportunity to earn financial incentives contingent on providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, in addition to health education on the health risks of stimulant use and substance injection. The control group will receive health education on the health risks of stimulants use and injection. All participants will participate in their syringe exchange services as usual. The investigators chose the health education as the control because participants across both conditions already receive the services provided by the syringe exchange program. Moreover, this control condition will help control for a potential type of between-groups variability. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05787847
Study type Interventional
Source University of Vermont
Contact Richard Rawson
Phone 310-951-9091
Email richard.rawson@uvm.edu
Status Recruiting
Phase N/A
Start date February 14, 2024
Completion date October 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT04061941 - Change in Cognitive Function in Stimulant Users
Not yet recruiting NCT05097547 - Contingency Management for Stimulant Use Disorders N/A
Recruiting NCT06073340 - The Longitudinal Study of Stimulant Use Disorder
Recruiting NCT04642820 - Drugs Brain and Behavior (DDP) Early Phase 1
Completed NCT05379959 - Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function Early Phase 1
Recruiting NCT05835921 - Enhancing Prospective Thinking in Early Recovery N/A
Not yet recruiting NCT06424184 - Accelerated rTMS for Substance Use Disorder and Depression N/A
Recruiting NCT05140876 - Supporting Treatment Adherence for Resilience and Thriving (START) N/A
Withdrawn NCT04553263 - Relapse Prevention in Stimulant Use Disorder Early Phase 1
Recruiting NCT04426214 - Neuromodulation and Cognitive Training for Substance Use Disorders N/A
Recruiting NCT04899024 - PrEP Affect Regulation Treatment Innovation N/A
Recruiting NCT03470480 - rTMS for Craving in Methamphetamine Use Disorder N/A
Active, not recruiting NCT04907357 - rTMS for Stimulant Use Disorders N/A
Recruiting NCT03935646 - Acute Effects of Stimulant Medication in College Students With ADHD Phase 2